Literature DB >> 27896620

Antimicrobial activity of topical agents against Propionibacterium acnes: an in vitro study of clinical isolates from a hospital in Shanghai, China.

Ying Ma1, Nanxue Zhang1, Shi Wu2, Haihui Huang2, Yanpei Cao3.   

Abstract

This study aimed to compare the antimicrobial activities of topical agents against Propionibacterium acnes isolated from patients admitted to a hospital in Shanghai, China. The minimal inhibitory concentrations of the cultured P. acnes were determined in accordance with the Clinical and Laboratory Standards Institute. Susceptibilities to clindamycin and erythromycin were compared in terms of gender, age, disease duration, previous treatment, and disease severity. A total of 69 P. acnes strains were isolated from 98 patients (70.41%). The susceptibility to triple antibiotic ointment (neomycin/bacitracin/polymyxin B) and bacitracin was 100%. The susceptibility to fusidic acid was 92.7%. The resistance rates to neomycin sulfate, erythromycin, and clindamycin were 11.7%, 49.3%, and 33.4%, respectively. The high resistance rate to clindamycin and erythromycin was significantly affected by gender, previous treatment, and disease severity rather than by age and disease duration. Topical antibiotics should not be used separately for long-term therapy to avoid multiresistance. The use of topical antibiotics should be determined by clinicians on the basis of clinical conditions.

Entities:  

Keywords:  Propionibacterium acnes; antimicrobial susceptibility/resistance; in vitro study; topical antibiotics

Mesh:

Substances:

Year:  2016        PMID: 27896620     DOI: 10.1007/s11684-016-0480-9

Source DB:  PubMed          Journal:  Front Med        ISSN: 2095-0217            Impact factor:   4.592


  18 in total

Review 1.  [Topical antibiotics and clinical use].

Authors:  Salih Cesur
Journal:  Mikrobiyol Bul       Date:  2002 Jul-Oct       Impact factor: 0.622

Review 2.  Emerging topical antimicrobial options for mild-to-moderate acne: a review of the clinical evidence.

Authors:  James Del Rosso
Journal:  J Drugs Dermatol       Date:  2008-02       Impact factor: 2.114

Review 3.  Propionibacterium acnes, an emerging pathogen: from acne to implant-infections, from phylotype to resistance.

Authors:  G G Aubin; M E Portillo; A Trampuz; S Corvec
Journal:  Med Mal Infect       Date:  2014-03-20       Impact factor: 2.152

4.  Topical antibiotics: therapeutic value or ecologic mischief?

Authors:  James Q Del Rosso; Grace K Kim
Journal:  Dermatol Ther       Date:  2009 Sep-Oct       Impact factor: 2.851

Review 5.  Fusidic acid in skin infections and infected atopic eczema.

Authors:  D Bonamonte; A Belloni Fortina; L Neri; A Patrizi
Journal:  G Ital Dermatol Venereol       Date:  2014-08       Impact factor: 2.011

Review 6.  Acne analysis, grading and computational assessment methods: an overview.

Authors:  Roshaslinie Ramli; Aamir Saeed Malik; Ahmad Fadzil Mohamad Hani; Adawiyah Jamil
Journal:  Skin Res Technol       Date:  2011-05-24       Impact factor: 2.365

7.  Prevalence and mechanisms of low- and high-level mupirocin resistance in staphylococci isolated from a Korean hospital.

Authors:  Hee-Jeong Yun; Sang Won Lee; Gyu Man Yoon; Su Yeon Kim; Sooyoung Choi; Yeong Seon Lee; Eung-Chil Choi; Sunghoon Kim
Journal:  J Antimicrob Chemother       Date:  2003-03       Impact factor: 5.790

Review 8.  Understanding innate immunity and inflammation in acne: implications for management.

Authors:  B Dreno; H P M Gollnick; S Kang; D Thiboutot; V Bettoli; V Torres; J Leyden
Journal:  J Eur Acad Dermatol Venereol       Date:  2015-06       Impact factor: 6.166

9.  Antibiotic-resistant acne: lessons from Europe.

Authors:  J I Ross; A M Snelling; E Carnegie; P Coates; W J Cunliffe; V Bettoli; G Tosti; A Katsambas; J I Galvan Peréz Del Pulgar; O Rollman; L Török; E A Eady; J H Cove
Journal:  Br J Dermatol       Date:  2003-03       Impact factor: 9.302

10.  Efficacy of mupirocin and rifampin used with standard treatment in the management of acne vulgaris.

Authors:  Farzin Khorvash; Fatemeh Abdi; Hessam H Kashani; Farahnaz Fatemi Naeini; Fariborz Khorvash
Journal:  Iran J Pharm Res       Date:  2013       Impact factor: 1.696

View more
  2 in total

1.  Comparative Proteomic Analysis of Membrane Vesicles from Clinical C. acnes Isolates with Differential Antibiotic Resistance.

Authors:  Min Jiang; Xiaoyao Fan; Ziqi Jiang; Huyan Chen; Ye Liu; Tianze Yu; Qiong Huang; Ying Ma
Journal:  Clin Cosmet Investig Dermatol       Date:  2022-04-17

2.  Cannabidiol Inhibits Inflammation Induced by Cutibacterium acnes-Derived Extracellular Vesicles via Activation of CB2 Receptor in Keratinocytes.

Authors:  Ziqi Jiang; Shanglin Jin; Xiaoyao Fan; Ke Cao; Ye Liu; Xuan Wang; Ying Ma; Leihong Xiang
Journal:  J Inflamm Res       Date:  2022-08-11
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.